Jump to content

Thailand not eligible to produce generic Molnupiravir anti-viral drug


snoop1130

Recommended Posts

7 hours ago, snoop1130 said:

Merck’s Molnupiravir anti-viral drug, which is shown to reduce hospitalisations and deaths among COVID-19 patients by 50%,

 

Wow those clinical trials where really expedited ..operation warp speed 2 ?  ????

  • Like 2
Link to comment
Share on other sites

Thailand has an army to protect it.  Why are the powers in charge afraid of the UN or Merck ?  You can save untold thousand and maybe hundreds of thousand with this easy and cheap to manufacture drug. Just say no to IMPERIALISM. screw the drug companies; make this drug available to save untold numbers of Thais for very cheap. Of course, you got to have a populace willing to fight Merck and west that wants outlandish profits at the expense of dead Thai's. 

YMMV, I could be wrong, way wrong. I don't have money to fight the drug companies on libel laws.

Edited by IAMHERE
add weasel words ; Thai Comput Law (TCL)
Link to comment
Share on other sites

18 hours ago, johng said:

 

Wow those clinical trials where really expedited ..operation warp speed 2 ?  ????

They had to stop the trials because the ones in the placebo group where dying (8) I believe, whereas the ones that received Molnupiravir made full recoveries, in other words it was that effective, suffice to say that if they kept testing people with more trials using the placebo method, that would be construed as being unethical with more deaths occurring for certain.  

Link to comment
Share on other sites

Income Groups in USD based on GNI per capita

Lower-middle income 1,046 – 4,095

Upper-middle income 4,096 -12,695

High income > 12,695

 

Gross National Income (GNI) calculates the total income earned by a nation's people and businesses, including investment income, regardless of where it was earned. It also covers money received from abroad such as foreign investment and economic development aid.

 

in 2020 Thailand has a per capita GNI of 7050USD ranked 77 among the world economies, so it's an upper-middle income country.

 

For comparison China 10610USD, Malaysia 10581USD,  Indonesia 3870USD, Philippines 3420USD, Vietnam 2660, Myanmar 1260USD

 

 

Link to comment
Share on other sites

On 10/30/2021 at 11:55 AM, vinny said:
Quote

The problem is that suboptimal concentrations of the drug could also supercharge the creation of viral variants, introducing a wealth of mutations that aren’t quite enough to stop replication but are enough to drastically change how SARS-CoV-2 operates, either its transmissibility, stability or virulence. While we consider the monetary costs of the drug, we cannot overlook the evolutionary costs of introducing such a powerful mutagen into our Covid-19 environment. The FDA should ensure the safety of the drug before approval, and insist on a full accounting of all data on the drug’s potential to supercharge viral variants.

 

The possibility of a new drug to ward off the most serious symptoms of Covid-19 is welcome news indeed, but we still must question whether the financial cost and the risk of new variants is a price we’re willing to pay.

See also Using a Virus’s Knack for Mutating to Wipe It Out
 

Quote

But T7 did not wither away as they had predicted. After evolving for 200 generations in the presence of the drug, the viruses ended up replicating 90 percent faster than their ancestors.

My concerns are that this drug may create worst airborne viruses?

 

 

Edited by vinny
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.







×
×
  • Create New...